期刊文献+

CA19-9在大肠癌组织中的表达及临床意义

The Expressions of Associated Antigen CA19-9 in Colorectal Carcinoma
原文传递
导出
摘要 目的:本实验旨在研究肿瘤相关抗原CA19-9在大肠癌组织中的表达情况。方法:采用免疫组织化学方法对31例大肠癌及29例正常肠粘膜组织中的CA19-9的表达情况进行检测。结果:31例大肠癌CA19-9阳性表达22例(70.9%,22/31)。其中胞浆和胞膜均阳性的14例(63.6%,14/22),仅胞膜阳性的6例(30.3%,6/22)。正常肠粘膜组织中CA19-9表达为阴性。统计学分析显示CA19-9阳性表达与大肠癌组织分型相关(P<0.05)。结论:大肠组织中CA19-9的表达可能成为大肠癌的肿瘤标志之一,突出显现于低分化腺癌和粘液癌中的高表达。 Objective:To study the expression of the tumor associated antigen CA19-9 in colorectal carcinoma.Methods:The expressions of CA19-9 were detected by immunohistochemistry in 31 colorectal carcinoma and normal tissues.Results:There were 22 positive samples in 31 colorectal carcinoma(70.9%,22/31).Among them,14 samples were both positive in cytoplasm and plasmalemma(63.6%,14/22).The expressions of CA19-9 were negative in normal tissues.Statistical analyses pointed out that positive expression of CA19-9 were related to the types of gastric cancers(P0.05).Conclusion:The expression of CA19-9 in colorectal carcinoma seem be one of the markers,it had especial significance in low differentiation tumor and mucinous carcinoma.
出处 《中国伤残医学》 2010年第4期58-59,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 CA19-9 大肠癌 免疫组织化学 CA19-9 colorectal Carcinoma Immunohistochemistry
  • 相关文献

参考文献6

二级参考文献34

  • 1赵双罗,刘东刚,李建国,张波壮,杨华.糖链抗原19-9放免测定对诊断胃肠道潜隐癌的价值[J].中国肿瘤临床,1995,22(5):312-314. 被引量:10
  • 2罗家齐,王育敏,陈淑清,刘光明,李萍.慢性肝病患者血清糖抗原19-9含量变化及临床意义[J].临床肝胆病杂志,1995,11(2):85-86. 被引量:9
  • 3吴秀梅,徐龙宝,于静萍,肖溶,戴传箴.CEA、CA19-9和CA-50联合检测在胃肠道癌诊断中的作用[J].南京医科大学学报(自然科学版),1996,16(2):191-192. 被引量:3
  • 4张太平,赵玉沛.胰腺癌的肿瘤标志物[J].中国实验诊断学,1997,1(3):11-13. 被引量:9
  • 5伊伯元.放谢免疫分析在医学中的应用[M].北京:原子能出版社,1991.332.
  • 6Hayashi N, Nakamori S,Okami J,et al. Asscciation between expression levels of CA 19-9 and N-acetylglucosaminee-beta; 1,3-galactosyltransferase 5gene in human pancreatic cancer tissun[ J ]. Pathobiology, 2003,71 ( 1 ): 26~34.
  • 7Macchia V, Gargiulo M. Cyclic AMP-dependent secretion of CA 19-9 by LS174T human colon carcinoma cells[ J]. Oncol Rep, 2002, 9 (2): 387 ~391.
  • 8元雄良治.肿瘤标志物在癌诊断的灵敏度及特异度[J].日本临床,1996,54(6):121-125.
  • 9Kim HJ,Lee KT, Kim SH,et al. Differential diagnosis of intrahepatic bile duct dilatation without demonstrable mass on ultrasonography or CT: Benign versus malignancy [ J ]. J Gastroenterol Hepatol.2003, 18 ( 11 ): 1 287 ~1292.
  • 10Kokhanenko NIU, Ignashov AM, Varga EV, et al. Role of the tumor markers CA 19-9 and carcinoembryonic antigen(CEA)in diagnosis, treatment and prognosis of pancreatic cancer[J].Vopr 0nkol.2001,47(3) :294~ 297.

共引文献221

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部